First Patient Dosed in EVICTION Trial Evaluating ImCheck’s Lead Anti-Cancer Drug, ICT01: A Novel Gamma Delta T Cell-Activating Immunotherapy
Dit persbericht is enkel in het Engels beschikbaar.
Do you want to stay updated about the press releases?
Dit persbericht is enkel in het Engels beschikbaar.